Abstract
Pre-exposure prophylaxis (PrEP) for HIV prevention is underutilized by cisgender women at risk for HIV in the USA. Published research on PrEP initiation among cisgender women at risk for HIV focuses on identifying barriers and facilitators associated with intention to initiate, but few apply a behavioral theoretical lens to understand the relative importance of these diverse factors. This study provides a theoretically grounded view of the relative importance of factors associated with intention to initiate PrEP. We conducted an anonymous, cross-sectional survey of 1437 cisgender women seeking care at family planning and sexual health clinics to evaluate hypothesized barriers and facilitators of PrEP initiation. We categorized cisgender women with ≥ 3 behavioral risk-factors as “high-risk” for HIV acquisition; 26.9% (N = 387) met high-risk criterion. Among cisgender women in the high-risk sample, the majority were Black and single. Perceived risk of HIV acquisition was low and 13.7% reported intention to initiate PrEP. Positive attitudes toward PrEP, self-efficacy, perceived support from medical providers and social networks, and prior discussion about PrEP with medical providers were associated with intention to initiate PrEP; stigma was negatively associated. Background characteristics (other than age), risk factors for HIV acquisition, prior awareness of PrEP, and perceived risk of HIV were not associated with uptake intention. These findings support interventions that center on the role of providers in the provision of PrEP and on social networks in destigmatization of PrEP use.
This is a preview of subscription content, access via your institution.
Notes
There were no statistical differences in demographic characteristics (such as race, relationship status, educational level, income, employment status, and insurance status) between women with missing information on intention to initiate PrEP and those with complete information.
References
Aaron, E., Blum, C., Seidman, D., Hoyt, M. J., Simone, J., Sullivan, M., & Smith, D. K. (2018). Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care and STDs, 32(1), 16–23. https://doi.org/10.1089/apc.2017.0201
Ajzen, I. (2011). The theory of planned behaviour: Reactions and reflections. Psychology and Health, 26(9), 1113–1127. https://doi.org/10.1080/08870446.2011.613995
Ajzen, L., Albarracin, D., & Hornik, R. (2012). Prediction and change of health behavior: Applying the reasoned action approach. In I. Ajzen, D. Albarracin, & R. Hornik (Eds.), Prediction and change of health behavior: Applying the reasoned action approach (pp. 3–21). Taylor and Francis. https://doi.org/10.4324/9780203937082
Albarracín, D., Fishbein, M., Johnson, B. T., & Muellerleile, P. A. (2001). Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychological Bulletin, 127(1), 142–161. https://doi.org/10.1037/0033-2909.127.1.142
Armitage, C. J., & Conner, M. (2001). Efficacy of the theory of planned behaviour: A meta-analytic review. British Journal of Social Psychology, 40(4), 471–499. https://doi.org/10.1348/014466601164939
AtlasPlus | NCHHSTP | CDC. (n.d.). Retrieved January 7, 2021, from https://www.cdc.gov/nchhstp/atlas/index.htm
Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., & Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/NEJMoa1108524
Baldwin, A., Light, B., & Allison, W. E. (2021). Pre-exposure prophylaxis (PrEP) for HIV infection in cisgender and transgender women in the U.S.: A narrative review of the literature. Archives of Sexual Behavior, 50(4), 1713–1728. https://doi.org/10.1007/S10508-020-01903-8
Bogorodskaya, M., Lewis, S. A., Krakower, D. S., & Avery, A. (2020). Low awareness of and access to pre-exposure prophylaxis but high interest among heterosexual women in Cleveland, Ohio. Sexually Transmitted Diseases, 47(2), 96–99. https://doi.org/10.1097/OLQ.0000000000001082
Bradley, E., Forsberg, K., Betts, J. E., DeLuca, J. B., Kamitani, E., Porter, S. E., Sipe, T. A., & Hoover, K. W. (2019). Factors affecting pre-exposure prophylaxis implementation for women in the United States: A systematic review. Journal of Women’s Health (2002), 28(9), 1272–1285. https://doi.org/10.1089/jwh.2018.7353
Bradley, E. L. P., & Hoover, K. W. (2019). Improving HIV preexposure prophylaxis implementation for women: Summary of key findings from a discussion series with women’s HIV prevention experts. Women’s Health Issues, 29(1), 3–7. https://doi.org/10.1016/j.whi.2018.08.004
Brant, A. R., Dhillon, P., Hull, S., Coleman, M., Ye, P. P., Lotke, P. S., Folan, J., & Scott, R. K. (2020). Integrating HIV pre-exposure prophylaxis into family planning care: A RE-AIM framework evaluation. AIDS Patient Care and STDs, 34(6), 259–266. https://doi.org/10.1089/apc.2020.0004
Bush, S., Magnuson, D., Rawlings, M., Hawkins, T., McCallister, S., & Mera Giler, R. (2016, June 16–20). Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US [Conference Presentation]. ASM/ICAAC, Boston, MA.
Bush, S., Ng, L., Magnuson, D., Piontkowsky, D., & Mera Giler, R. (2015, June 28–30). Significant uptake of Truvada for preexposure prophylaxis (PrEP) utilization in the US in late 2014—1Q2015 [Conference Presentation]. IAPAC Treatment, Prevention, and Adherence Conference, Miami, FL.
Calabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., Willie, T. C., Caldwell, A., Kaplan, C., & Kershaw, T. S. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood. Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53. https://doi.org/10.1097/QAI.0000000000001762
Carley, T., Siewert, E., & Naresh, A. (2019). Interest in pre-exposure prophylaxis (PrEP) for HIV is limited among women in a general obstetrics & gynecology setting. AIDS and Behavior, 23(10), 2741–2748. https://doi.org/10.1007/S10461-019-02529-1
Chittamuru, D., Frye, V., Koblin, B. A., Brawner, B., Tieu, H.-V., Davis, A., & Teitelman, A. M. (2020). PrEP stigma, HIV stigma, and intention to use PrEP among women in New York City and Philadelphia. Stigma and Health, 5(2), 240–246. https://doi.org/10.1037/SAH0000194
Collier, K. L., Colarossi, L. G., & Sanders, K. (2017). Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: Community and provider perspectives. Journal of Health Communication, 22(3), 183–189. https://doi.org/10.1080/10810730.2016.1261969
Elion, R., & Coleman, M. (2016). The preexposure prophylaxis revolution: From clinical trials to routine practice: Implementation view from the USA. Current Opinion in HIV and AIDS, 11(1), 67–73. https://doi.org/10.1097/COH.0000000000000222
Felsher, M., Ziegler, E., Smith, L. R., Sherman, S. G., Amico, K. R., Fox, R., Madden, K., & Roth, A. M. (2020). An exploration of pre-exposure prophylaxis (PrEP) initiation among women who inject drugs. Archives of Sexual Behavior, 49(6), 2205–2212. https://doi.org/10.1007/S10508-020-01684-0
Fishbein, M., & Ajzen, I. (2011). Predicting and changing behavior: The reasoned action approach. Taylor and Francis.
Flash, C. A., Dale, S. K., & Krakower, D. S. (2017). Pre-exposure prophylaxis for HIV prevention in women: Current perspectives. International Journal of Women’s Health, 9, 391–401. https://doi.org/10.2147/IJWH.S113675
Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2016). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 29, 751–758. https://doi.org/10.1080/09540121.2016.1234679
Godin, G., & Kok, G. (1996). The theory of planned behavior: A review of its applications to health-related behaviors. American Journal of Health Promotion, 11(2), 87–98. https://doi.org/10.4278/0890-1171-11.2.87
Goparaju, L., Experton, L. S., & Praschan, N. C. (2015). Women want Pre-exposure prophylaxis but are advised against it by their HIV-positive counterparts. Journal of AIDS & Clinical Research, 6(11). https://doi.org/10.4172/2155-6113.1000522
Goparaju, L., Praschan, N. C., Jeanpiere, L. W., Experton, L. S., Young, M. A., & Kassaye, S. (2017). Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. Journal of AIDS & Clinical Research, 8. https://doi.org/10.4172/2155-6113.1000730
Hess, K. L., Hu, X., Lansky, A., Mermin, J., & Hall, H. I. (2017). Lifetime risk of a diagnosis of HIV infection in the United States. Annals of Epidemiology, 27(4), 238–243. https://doi.org/10.1016/j.annepidem.2017.02.003
Hill, L. M., Lightfoot, A. F., Riggins, L., & Golin, C. E. (2021). Awareness of and attitudes toward pre-exposure prophylaxis among African American women living in low-income neighborhoods in a Southeastern city. AIDS Care, 33, 239–243. https://doi.org/10.1080/09540121.2020.1769834
Hirschhorn, L., Brown, R., Friedman, E. E., Christeller, C., Greene, G. J., Bender, A., Bouris, A., Modali, L., Johnson, A. K., Pickett, J., & Ridgway, J. (2019). Women’s PrEP knowledge, attitudes, preferences and experience in Chicago. CROI conference. Retrieved April 10, 2020, from http://www.croiconference.org/sessions/women’s-prep-knowledge-attitudes-preferences-and-experience-chicago
HIV Mortality 2017. (n.d.). Retrieved January 7, 2021, from http://www.cdc.gov/nchs/deaths.htm
Hull, S. J. (2012). Perceived risk as a moderator of the effectiveness of framed HIV-test promotion messages among women: A randomized controlled trial. Health Psychology, 31(1), 114–121. https://doi.org/10.1037/a0024702
Hull, S. J., Bowleg, L., Perez, C., & Sichone-Cameron, M. (2017). Psychosocial and environmental factors affecting Black women’s consideration of PrEP as a viable prevention tool: Implications for strategic communication [Abstract 4038.0]. APHA. https://apha.confex.com/apha/2017/meetingapp.cgi/Paper/376849
Johnson, A. K., Fletcher, F. E., Ott, E., Wishart, M., Friedman, E. E., Terlikowski, J., & Haider, S. (2020). Awareness and intent to use pre-exposure prophylaxis (PrEP) among African American women in a family planning clinic. Journal of Racial and Ethnic Health Disparities, 7(3), 550–554. https://doi.org/10.1007/S40615-019-00683-9
Koren, D. E., Nichols, J. S., & Simoncini, G. M. (2018). HIV pre-exposure prophylaxis and women: Survey of the knowledge, attitudes, and beliefs in an urban obstetrics/gynecology clinic. AIDS Patient Care and STDs, 32(12), 490–494. https://doi.org/10.1089/apc.2018.0030
Kwakwa, H. A., Bessias, S., Sturgis, D., Mvula, N., Wahome, R., Coyle, C., & Flanigan, T. P. (2016). Attitudes toward HIV pre-exposure prophylaxis in a United States urban clinic population. AIDS and Behavior, 20(7), 1443–1450. https://doi.org/10.1007/s10461-016-1407-9
Kwakwa, H. A., Bessias, S., Sturgis, D., Walton, G., Wahome, R., Gaye, O., & Jackson, M. (2018). Engaging United States black communities in HIV pre-exposure prophylaxis: Analysis of a PrEP engagement cascade. Journal of the National Medical Association, 110(5), 480–485. https://doi.org/10.1016/j.jnma.2017.12.006
Mapping PrEP: First ever data on PrEP users across the U.S.—AIDSVu. (n.d.). Retrieved November 6, 2019, from https://aidsvu.org/prep/
McEachan, R., Taylor, N., Harrison, R., Lawton, R., Gardner, P., & Conner, M. (2016). Meta-analysis of the reasoned action approach (RAA) to understanding health behaviors. Annals of Behavioral Medicine, 50(4), 592–612. https://doi.org/10.1007/s12160-016-9798-4
Murnane, P. M., Celum, C., Mugo, N., Campbell, J. D., Donnell, D., Bukusi, E., Mujugira, A., Tappero, J., Kahle, E. M., Thomas, K. K., Baeten, J. M., & Partners PrEP Study Team. (2013). Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: Subgroup analyses from a randomized trial. AIDS, 27(13), 2155–2160. https://doi.org/10.1097/QAD.0b013e3283629037
Nydegger, L. A., Dickson-Gomez, J., & Ko Ko, T. (2020). A longitudinal, qualitative exploration of perceived HIV risk, healthcare experiences, and social support as facilitators and barriers to PrEP adoption among black women. AIDS and Behavior, 25(2), 582–591. https://doi.org/10.1007/S10461-020-03015-9
Ojikutu, B. O., Bogart, L. M., Higgins-Biddle, M., Dale, S. K., Allen, W., Dominique, T., & Mayer, K. H. (2018). Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS and Behavior, 22(11), 3576–3587. https://doi.org/10.1007/s10461-018-2067-8
Patel, A. S., Goparaju, L., Sales, J. M., Mehta, C. C., Blackstock, O. J., Seidman, D., Ofotokun, I., Kempf, M. C., Fischl, M. A., Golub, E. T., Adimora, A. A., French, A. L., Dehovitz, J., Wingood, G., Kassaye, S., & Sheth, A. N. (2019). PrEP eligibility among at-risk women in the Southern United States: Associated factors, awareness, and acceptability. Journal of Acquired Immune Deficiency Syndromes, 80(5), 527–532. https://doi.org/10.1097/QAI.0000000000001950
Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267. https://doi.org/10.1007/s10461-016-1625-1
Phillips, G., Raman, A. B., Felt, D., McCuskey, D. J., Hayford, C. S., Pickett, J., Lindeman, P. T., & Mustanski, B. (2020). PrEP4Love. JAIDS Journal of Acquired Immune Deficiency Syndromes, 83(5), 450–456. https://doi.org/10.1097/QAI.0000000000002297
Rubtsova, A., Wingood, G., Dunkle, K., Camp, C., & DiClemente, R. (2014). Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): Results of a National Survey. Current HIV Research, 11(7), 543–548. https://doi.org/10.2174/1570162x12666140129104952
Sheeran, P. (2002). Intention—Behavior relations: A conceptual and empirical review. European Review of Social Psychology, 12(1), 1–36. https://doi.org/10.1080/14792772143000003
Sheppard, B. H., Hartwick, J., & Warshaw, P. R. (1988). The theory of reasoned action: A meta-analysis of past research with recommendations for modifications and future research. Journal of Consumer Research, 15(3), 325–343. https://doi.org/10.1086/209170
Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012). Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Education and Prevention, 24(5), 408–421. https://doi.org/10.1521/aeap.2012.24.5.408
Smith, D. K., van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850-857.e9. https://doi.org/10.1016/j.annepidem.2018.05.003
Teitelman, A. M., Chittamuru, D., Koblin, B. A., Davis, A., Brawner, B. M., Fiore, D., Broomes, T., Ortiz, G., Lucy, D., & Tieu, H.-V. (2020). Beliefs associated with intention to use PrEP among cisgender U.S. women at elevated HIV risk. Archives of Sexual Behavior, 49(6), 2213–2221. https://doi.org/10.1007/S10508-020-01681-3
Teitelman, A. M., Tieu, H. V., Dalmacio, F., Bannon, J., Brawner, B. M., Davis, A., Gugery, P., & Koblin, B. (2022). Individual, social and structural factors influencing PrEP uptake among cisgender women: A theory-informed elicitation study. AIDS Care, 34, 273–283. https://doi.org/10.1080/09540121.2021.1894319
Tekeste, M., Hull, S., Dovidio, J. F., Safon, C. B., Blackstock, O., Taggart, T., Kershaw, T. S., Kaplan, C., Caldwell, A., Lane, S. B., & Calabrese, S. K. (2018). Differences in medical mistrust between black and white women: Implications for patient-provider communication about PrEP. AIDS and Behavior, 23(7), 1737–1748. https://doi.org/10.1007/S10461-018-2283-2
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., & Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. https://doi.org/10.1056/NEJMoa1110711
Tims-Cook, Z. (2019). A Retrospective assessment of antecedent pre-exposure prophylaxis eligibility of HIV-positive women in the South. AIDS Patient Care and STDs, 33(9), 384–387. https://doi.org/10.1089/apc.2019.0046
Turner, L., Roepke, A., Wardell, E., & Teitelman, A. M. (2018). Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP. Journal of the Association of Nurses in AIDS Care, 29(1), 83–92. https://doi.org/10.1016/j.jana.2017.11.002
What is PrEP? - YouTube. (n.d.).
Willie, T., Kershaw, T., Campbell, J. C., & Alexander, K. A. (2017). Intimate partner violence and PrEP acceptability among low-income, young black women: Exploring the mediating role of reproductive coercion. AIDS and Behavior, 21(8), 2261–2269. https://doi.org/10.1007/s10461-017-1767-9
Wingood, G. M., Dunkle, K., Camp, C., Patel, S., Painter, J. E., Rubtsova, A., & DiClemente, R. J. (2013). Racial differences and correlates of potential adoption of preexposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes, 63, S95–S101. https://doi.org/10.1097/QAI.0b013e3182920126
Acknowledgements
The authors would like to thank Drs. Ron Migues and Patricia Tanjutco from MedStar Health Institute for their administrative support and the clinical teams at DC Health and MedStar Washington Hospital Center Family Planning and Preventative Care for their participation and support.
Funding
Data reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001409, the National Institute on Drug Abuse under Award Number 1K01DA050496-01A1a, and an Investigator Sponsored Research Award from Gilead Sciences (ISR-17-10227). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Participation of Human Subjects/Consent
IRB approval was obtained from the respective IRBs prior to initiation of the study and maintained throughout IRB#s 2017-0870 and 2017–25. Written consent was obtained from all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Scott, R.K., Hull, S.J., Huang, J.C. et al. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.. Arch Sex Behav 51, 2613–2624 (2022). https://doi.org/10.1007/s10508-021-02274-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-021-02274-4